Postoperative delirium (One study used DRS, three studies used CAM and in one study diagnostic tool was not reported) Time points were up to 4 days postoperatively
It is very uncertain whether summary of findings TIVA changes postoperative delirium (One study used DRS, three studies used CAM… compared with inhalational maintenance of anaesthesia (very low certainty).
1 finding from 1 review
Postoperative cognitive dysfunction (9 studies used MMSE, and 2 of these studies used additional diagnostic tools; 1 study used Trail Making Test and additional diagnostic tools; 3 studies did not report diagnostic tools) Time points were up to 30...
Summary of findings TIVA may leads to lower postoperative cognitive dysfunction (9 studies used MMSE, and 2 of… compared with inhalational maintenance of anaesthesia (low certainty).
1 finding from 1 review
Mortality at 30 days
It is very uncertain whether summary of findings TIVA changes mortality At 30 days compared with inhalational maintenance of anaesthesia (very low certainty).
1 finding from 1 review
Intraoperative hypotension (defined by study authors as change in MAP from baseline)
1 finding from 1 review
Length of stay in PACU
1 finding from 1 review
Length of hospital stay
1 finding from 1 review
Recurrence of pterygium · people with primary or recurrent pterygium
It is very uncertain whether summary of findings for conjunctival autograft changes recurrence of pterygium compared with amniotic membrane transplant (very low certainty).
2 findings from 1 review
Clinical improvement (non‐recurrence risk) · people with primary or recurrent pterygium
The review found no eligible studies for this question.
1 finding from 1 review
Need for repeat surgery · people with primary or recurrent pterygium
The review found no eligible studies for this question.
1 finding from 1 review
Visual acuity · people with primary or recurrent pterygium
The review found no eligible studies for this question.
1 finding from 1 review
Quality of life · people with primary or recurrent pterygium
The review found no eligible studies for this question.
1 finding from 1 review
Costs (direct and indirect) · people with primary or recurrent pterygium
The review found no eligible studies for this question.
1 finding from 1 review
Death or dependence (mRS 4 to 6) at day 90 · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Recombinant activated factor VII showed no clear difference in death or dependence (mRS 4–6) compared with placebo/open control (low certainty).
1 finding from 1 review
Intracerebral haemorrhage expansion by 24 hours · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Recombinant activated factor VII showed no clear difference in intracerebral haemorrhage expansion by 24 hours compared with placebo/open control (low certainty).
1 finding from 1 review
All serious adverse events · adults with acute spontaneous intracerebral haemorrhage
It is very uncertain whether summary of findings table ‐ Recombinant activated factor VII changes all serious adverse events compared with placebo/open control (very low certainty).
1 finding from 1 review
Death from any cause · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Recombinant activated factor VII showed no clear difference in death from any cause compared with placebo/open control (moderate certainty).
1 finding from 1 review
Quality of life ‐ not reported · adults with acute spontaneous intracerebral haemorrhage
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mood ‐ not reported · adults with acute spontaneous intracerebral haemorrhage
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive function ‐ not reported · adults with acute spontaneous intracerebral haemorrhage
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Survival · adults with cystic fibrosis and either F508del/MF or F508del/F508del genotype
1 finding from 1 review